A retrospective study assessing the hemostatic efficacy and thromboembolic complication rate with the use of activated prothrombin complex concentrates for Direct Oral Anticoagulants associated bleeding
Latest Information Update: 29 Jun 2021
At a glance
- Drugs Factor VIII inhibitor bypassing fraction (Primary)
- Indications Haemorrhage
- Focus Adverse reactions; Therapeutic Use
- 29 Jun 2021 New trial record